Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Feb 5, 2024
| Brian Hart
AAM White Paper: Hatch-Waxman Turns 40
Press Release
Jan 23, 2024
| Brian Hart
Keren Haruvi Named Chair of the Association for Accessible Medicines Board of Directors
Press Release
Jan 23, 2024
| Brian Hart
AAM Requests Federal Injunction to Block Illinois’ Unconstitutional Drug Price Law
Press Release
Dec 8, 2023
| Brian Hart
Keren Haruvi Announced as Chair of the Association for Accessible Medicines Board of Directors
Press Release
Nov 15, 2023
| Brian Hart
AAM Statement on IQVIA Institute Report Examining Drug Shortages
Video
Nov 3, 2023
| Jennifer Soup
Join Us at Access! 2024 in Tampa, Florida
Blog
Oct 20, 2023
| AAM
2023 Report
Blog
Oct 18, 2023
| Jennifer Soup
GRx+Biosims 2023 Conference Recap
Blog
Sep 13, 2023
| Jewel Smith
Member Spotlight: Biocon Biologics
Press Release
Sep 6, 2023
| Monét Stanford
Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022
Report
Sep 6, 2023
| Monét Stanford
Report: 2023 U.S. Generic and Biosimilar Medicines Savings Report
Blog
Jul 17, 2023
| Craig Burton
Pharmacy Benefit Managers Are Blocking Patient Access to Biosimilar Insulin
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action